KRAS somatic mutations were found to be more frequent in patients with deep infiltrating endometriosis or endometrioma lesions and patients with mixed subtypes, compared to those with superficial endometriosis only (Orr et al., 2023). This evidence concerns the gene KRAS and endometriosis.